Furthermore, owing to its selective expression in repaired or reshaped tissues, FAP is considered a biomarker for activating fibroblasts in arthritis, autoimmune disorders, cardiovascular diseases (CVD), fibrosis, and metabolic diseases (21), since these nonmalignant diseases show an upgraded expression of FAP, which is associated with disease progression (20–23). The gene discussed is FAP; the disease is Other metabolic disease.